Heart Rhythm Society (HRS)

The Heart Rhythm Society (HRS) is the primary U.S. medical society for electrophysiology (EP). The organization promotes education and advocacy for cardiac arrhythmia professionals and patients, including setting policy guidelines and offering expert consensus.

Andrea Russo inducted as HRS president

Cardiologist Andrea M. Russo, MD, took the reins of the Heart Rhythm Society as president this month after an induction ceremony at the organization’s annual meeting in San Francisco.

May 23, 2019

HRS releases consensus statement on arrhythmogenic cardiomyopathy: 5 things to know

The Heart Rhythm Society issued a first-ever consensus statement on the evaluation, risk stratification and management of arrhythmogenic cardiomyopathy at its annual conference in San Francisco this spring.

May 13, 2019
Christine Albert, MD, MPH

Program chair previews HRS.19 highlights

The Heart Rhythm Society's 2019 scientific sessions will be held May 8-11 in San Francisco, a venue that enabled the program committee to tap into Silicon Valley’s expertise with digital health, emerging technology and innovation. HRS.19 Program Director Christine Albert, MD, MPH, gave Cardiovascular Business a preview of meeting highlights.

April 16, 2019

Patricia Blake named new CEO of Heart Rhythm Society

Patricia V. Blake will take over as CEO of the Heart Rhythm Society (HRS) next March, HRS leadership announced Oct. 26.

October 26, 2018
cover_story.jpg

Targeting Unnecessary Practice Variation: A Conversation About Quality, Cost & Becoming a High-reliability Organization

Is practice variation a real problem or a passing trend? Which metrics matter? Are there practical approaches healthcare leaders should use to tackle variation and, if so, how can they get their teams on board? Cardiologists and administrators weigh in.

September 18, 2018

Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon

DUBLIN and MUNICH — August 28, 2018 — Medtronic plc (NYSE:MDT) today announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life, reduced symptoms from abnormal heart rhythms, and low incidence of reinterventions and repeat ablation procedures.

August 28, 2018

New Study Demonstrates Feasibility of Novel Mechanical Sensor in Medtronic Micra Transcatheter Pacing System to Detect Atrial Contractions and Restore AV Synchrony

DUBLIN and BOSTON — May 11, 2018 — Medtronic plc (NYSE:MDT) today announced new clinical study results demonstrating that an investigational algorithm, utilizing the accelerometer signal in the Micra(TM) Transcatheter Pacing System (TPS) may restore AV synchrony, improving cardiac function in patients with sinus rhythm and atrioventricular (AV) block.

May 14, 2018

AFib ablation outperforms drugs in CABANA trial

Catheter ablation was found to be superior to optimal drug therapy for the primary treatment of atrial fibrillation (AFib) in the randomized CABANA trial presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston. However, there was a caveat.

May 11, 2018

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup